牛叉诊股

[{"date":"2026.11.10","stock":"0.67","trade":"0.88","ind":"0.86"},{"date":"2026.11.09","stock":"-1.84","trade":"-0.20","ind":"-0.27"},{"date":"2026.11.06","stock":"-2.31","trade":"-0.80","ind":"-2.57"},{"date":"2026.11.05","stock":"1.70","trade":"1.29","ind":"1.19"},{"date":"2026.11.04","stock":"0.66","trade":"0.85","ind":"4.22"},{"date":"2026.11.03","stock":"1.60","trade":"0.44","ind":"-1.21"},{"date":"2026.11.02","stock":"1.49","trade":"1.93","ind":"1.63"},{"date":"2026.10.30","stock":"-0.54","trade":"-0.03","ind":"-2.73"},{"date":"2026.10.29","stock":"-0.40","trade":"-1.62","ind":"-2.92"},{"date":"2026.10.28","stock":"-1.06","trade":"0.86","ind":"2.02"},{"date":"2026.10.27","stock":"-2.34","trade":"-2.32","ind":"-2.50"},{"date":"2026.10.26","stock":"-0.26","trade":"0.48","ind":"-1.19"},{"date":"2026.10.23","stock":"0.13","trade":"0.88","ind":"2.79"},{"date":"2026.10.22","stock":"-1.66","trade":"-2.52","ind":"-2.96"},{"date":"2026.10.21","stock":"-1.00","trade":"-0.15","ind":"-0.82"},{"date":"2026.10.20","stock":"-0.75","trade":"-0.28","ind":"-0.14"},{"date":"2026.10.19","stock":"0.12","trade":"0.26","ind":"0.13"},{"date":"2026.10.16","stock":"-0.86","trade":"-0.12","ind":"-0.12"},{"date":"2026.10.15","stock":"-0.61","trade":"-1.40","ind":"-2.43"},{"date":"2026.10.14","stock":"-1.21","trade":"-0.46","ind":"-1.97"},{"date":"2026.10.13","stock":"1.60","trade":"-0.13","ind":"-0.25"}]

佛慈制药,深证成指,中药指数

压力支撑

该股压力位为7.50元，支撑位为7.41元。

[{"text":"\u538b\u529b\u4f4d","value":"7.50","date":1794240000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.41","date":1794240000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.4资金面打败了65%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月11日 12:51

机构今日流向(万元)	-877.58	机构5日流向(万元)	-2074.68
机构10日流向(万元)	490.24	机构20日流向(万元)	-3467.34

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量增加238.04万股，其中基金净减仓3家，主力净增仓20家，请投资者中长期谨慎为宜。

截止2026-06-30，共40家主力机构（基金38家，一般法人2家），持仓量总计32472.97万股，占流通A股63.59%
其中，基金持仓与2025-12-31相比：
增仓：2家，增持 9.34万股
减仓：5家，减持 13.07万股
新出现在主力名单中：31家，持有535.97万股
从主力名单中消失：11家，原持有294.2万股

消息面诊股

诊断结果：5.6消息面打败了22%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	因工作调动原因	2026-11-07
一般消息	股东大会	临时股东大会	2026-08-20
利好	分红转增	10派0.6元(含税)	2026-08-20
一般消息	重大事项	关联交易	2026-08-20
一般消息	高管变动	因个人原因	2026-07-28
一般消息	资产重组	公司股权转让	2026-06-13
一般消息	重大事项	关联交易	2026-05-09
利好	分红转增	10派0.2元(含税)	2026-04-09
一般消息	募资投向	公司购买资产	2026-03-10

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：7.8行业面打败了91%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.11.10","price":"0.86","value":"0.88"},{"date":"2026.11.09","price":"-0.27","value":"-0.20"},{"date":"2026.11.06","price":"-2.57","value":"-0.80"},{"date":"2026.11.05","price":"1.19","value":"1.29"},{"date":"2026.11.04","price":"4.22","value":"0.85"},{"date":"2026.11.03","price":"-1.21","value":"0.44"},{"date":"2026.11.02","price":"1.63","value":"1.93"},{"date":"2026.10.30","price":"-2.73","value":"-0.03"},{"date":"2026.10.29","price":"-2.92","value":"-1.62"},{"date":"2026.10.28","price":"2.02","value":"0.86"},{"date":"2026.10.27","price":"-2.50","value":"-2.32"},{"date":"2026.10.26","price":"-1.19","value":"0.48"},{"date":"2026.10.23","price":"2.79","value":"0.88"},{"date":"2026.10.22","price":"-2.96","value":"-2.52"},{"date":"2026.10.21","price":"-0.82","value":"-0.15"},{"date":"2026.10.20","price":"-0.14","value":"-0.28"},{"date":"2026.10.19","price":"0.13","value":"0.26"},{"date":"2026.10.16","price":"-0.12","value":"-0.12"},{"date":"2026.10.15","price":"-2.43","value":"-1.40"},{"date":"2026.10.14","price":"-1.97","value":"-0.46"},{"date":"2026.10.13","price":"-0.25","value":"-0.13"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	桂林三金	39.18%	7.91%	7.0分
2	维康药业	15.96%	20.85%	6.4分
3	羚锐制药	13.87%	-1.87%	7.2分
4	达仁堂	13.69%	-4.61%	5.6分
5	片仔癀	13.57%	-0.05%	6.1分
6	盘龙药业	12.50%	16.32%	5.6分
7	济川药业	9.39%	3.90%	7.2分
8	东阿阿胶	6.76%	0.38%	6.7分
9	步长制药	5.52%	-0.47%	6.3分
10	昆药集团	5.40%	-1.57%	5.8分
11	葵花药业	5.30%	-1.81%	5.9分
12	云南白药	5.25%	-1.58%	6.7分
13	以岭药业	5.18%	-0.63%	6.5分
14	恩威医药	4.04%	-1.62%	5.4分
15	*ST香雪	3.89%	26.07%	6.1分
16	马应龙	3.58%	-2.89%	6.4分
17	健民集团	3.36%	-2.07%	6.5分
18	天士力	3.13%	-1.87%	6.0分
19	信邦制药	3.07%	-2.27%	6.4分
20	康缘药业	2.70%	-1.10%	6.2分
21	华润三九	2.54%	-1.86%	6.9分
22	同仁堂	2.05%	-2.62%	5.2分
23	亚宝药业	1.16%	-0.14%	5.8分
24	华润江中	0.53%	-2.05%	6.7分
25	中恒集团	0.00%	3.69%	5.7分
26	康美药业	0.00%	-0.75%	5.5分
27	吉林敖东	-0.47%	-0.87%	5.4分
28	-	-0.65%	9.00%	分
29	白云山	-0.80%	-2.62%	5.4分
30	众生药业	-1.14%	13.41%	6.1分
31	奇正藏药	-1.29%	-1.34%	5.6分
32	新光药业	-2.04%	1.76%	4.3分
33	方盛制药	-2.49%	0.89%	5.2分
34	仁和药业	-2.68%	-0.97%	5.6分
35	红日药业	-2.75%	0.63%	5.4分
36	ST百灵	-3.08%	-0.68%	4.1分
37	三力制药	-3.26%	1.57%	5.8分
38	康恩贝	-3.43%	-3.21%	5.6分
39	陇神戎发	-3.68%	17.66%	6.0分
40	ST嘉应	-4.06%	5.41%	5.3分
41	ST葫芦娃	-4.56%	4.62%	5.3分
42	振东制药	-4.66%	3.15%	5.8分
43	九芝堂	-4.82%	1.55%	6.8分
44	特一药业	-4.83%	3.00%	5.5分
45	太极集团	-5.10%	0.23%	5.6分
46	珍宝岛	-5.14%	1.63%	5.6分
47	佐力药业	-5.79%	-0.56%	5.0分
48	上海凯宝	-6.74%	0.41%	5.4分
49	寿仙谷	-7.03%	0.00%	4.9分
50	华森制药	-7.28%	5.50%	6.5分
51	-	-7.41%	1.53%	分
52	汉森制药	-7.81%	4.69%	6.4分
53	千金药业	-8.00%	-0.74%	6.3分
54	佛慈制药	-8.30%	-1.18%	5.4分
55	广誉远	-8.72%	-1.09%	4.9分
56	新天药业	-10.56%	1.21%	5.5分
57	益佰制药	-10.89%	-0.31%	4.5分
58	ST金花	-11.43%	0.51%	5.0分
59	沃华医药	-12.08%	1.68%	6.6分
60	太龙药业	-12.15%	1.53%	5.6分
61	古汉医药	-14.02%	0.00%	4.8分
62	益盛药业	-14.29%	-0.17%	5.1分
63	华神科技	-16.55%	1.42%	5.4分
64	康惠股份	-17.18%	4.09%	5.2分
65	粤万年青	-17.66%	8.29%	4.9分
66	精华制药	-18.01%	2.31%	5.7分
67	ST万邦	-20.14%	7.70%	5.3分
68	天目药业	-25.49%	1.83%	5.0分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.7基本面打败了40%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（40分）

基本面得分最高的股票

[ 截止日期：2026-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 38/110 ， 56/110。

[{"date":"2026-09-30","value":"2.74","vol":"4.23"},{"date":"2026-06-30","value":"2.15","vol":"3.25"},{"date":"2026-03-31","value":"1.23","vol":"2.21"},{"date":"2025-12-31","value":"2.72","vol":"-2.33"},{"date":"2025-09-30","value":"2.11","vol":"4.80"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净资产收益率(%)	2.74	2.15	1.23	2.72	2.11
行业(%)	4.23	3.25	2.21	-2.33	4.80

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"32.31","vol":"52.92"},{"date":"2026-06-30","value":"33.19","vol":"53.70"},{"date":"2026-03-31","value":"37.13","vol":"55.05"},{"date":"2025-12-31","value":"34.09","vol":"52.85"},{"date":"2025-09-30","value":"32.92","vol":"53.29"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
销售毛利率(%)	32.31	33.19	37.13	34.09	32.92
行业(%)	52.92	53.70	55.05	52.85	53.29

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/110 ， 14/110。

[{"date":"2026-09-30","value":"4.19","vol":"-8.01"},{"date":"2026-06-30","value":"2.55","vol":"-9.08"},{"date":"2026-03-31","value":"-2.11","vol":"-5.58"},{"date":"2025-12-31","value":"-6.60","vol":"-6.76"},{"date":"2025-09-30","value":"-11.92","vol":"-7.84"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
营业收入同比增长率(%)	4.19	2.55	-2.11	-6.60	-11.92
行业(%)	-8.01	-9.08	-5.58	-6.76	-7.84

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"33.19","vol":"-22.29"},{"date":"2026-06-30","value":"32.00","vol":"-101.51"},{"date":"2026-03-31","value":"16.92","vol":"1.06"},{"date":"2025-12-31","value":"-18.08","vol":"-80.25"},{"date":"2025-09-30","value":"-2.54","vol":"-2.78"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净利润同比增长率(%)	33.19	32.00	16.92	-18.08	-2.54
行业(%)	-22.29	-101.51	1.06	-80.25	-2.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 46/110 ， 37/110。

[{"date":"2026-09-30","value":"0.25","vol":"0.33"},{"date":"2026-06-30","value":"0.17","vol":"0.22"},{"date":"2026-03-31","value":"0.08","vol":"0.12"},{"date":"2025-12-31","value":"0.36","vol":"0.47"},{"date":"2025-09-30","value":"0.25","vol":"0.35"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
总资产周转率(次)	0.25	0.17	0.08	0.36	0.25
行业(次)	0.33	0.22	0.12	0.47	0.35

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"1.47","vol":"1.72"},{"date":"2026-06-30","value":"0.98","vol":"1.14"},{"date":"2026-03-31","value":"0.46","vol":"0.59"},{"date":"2025-12-31","value":"1.92","vol":"2.34"},{"date":"2025-09-30","value":"1.24","vol":"1.72"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
存货增长率(次)	1.47	0.98	0.46	1.92	1.24
行业(次)	1.72	1.14	0.59	2.34	1.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-09-30","value":"15.32","vol":"13.37"},{"date":"2026-06-30","value":"45.63","vol":"20.65"},{"date":"2026-03-31","value":"26.46","vol":"5.83"},{"date":"2025-12-31","value":"31.03","vol":"30.77"},{"date":"2025-09-30","value":"38.84","vol":"10.53"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
现金流量净额/营业收入	15.32	45.63	26.46	31.03	38.84
行业	13.37	20.65	5.83	30.77	10.53

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.78","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.31","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资本支出／折旧和摊销	-	0.78	-	0.31	-
行业	0.00	0.88	0.00	1.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 34/110 ， 43/110。

[{"date":"2026-09-30","value":"2.94","vol":"3.18"},{"date":"2026-06-30","value":"2.88","vol":"3.10"},{"date":"2026-03-31","value":"3.04","vol":"2.97"},{"date":"2025-12-31","value":"3.02","vol":"2.94"},{"date":"2025-09-30","value":"3.10","vol":"3.09"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
流动比率	2.94	2.88	3.04	3.02	3.10
行业	3.18	3.10	2.97	2.94	3.09

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"2.19","vol":"2.39"},{"date":"2026-06-30","value":"2.15","vol":"2.34"},{"date":"2026-03-31","value":"2.30","vol":"2.23"},{"date":"2025-12-31","value":"2.27","vol":"2.15"},{"date":"2025-09-30","value":"2.21","vol":"2.24"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
速动比率	2.19	2.15	2.30	2.27	2.21
行业	2.39	2.34	2.23	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 27/110 ， 33/110。

[{"date":"2026-09-30","value":"27.82","vol":"31.42"},{"date":"2026-06-30","value":"28.13","vol":"32.07"},{"date":"2026-03-31","value":"27.11","vol":"31.94"},{"date":"2025-12-31","value":"27.17","vol":"32.43"},{"date":"2025-09-30","value":"26.86","vol":"31.59"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资产负债率(%)	27.82	28.13	27.11	27.17	26.86
行业(%)	31.42	32.07	31.94	32.43	31.59

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"0.39","vol":"0.67"},{"date":"2026-06-30","value":"0.40","vol":"0.68"},{"date":"2026-03-31","value":"0.38","vol":"0.66"},{"date":"2025-12-31","value":"0.38","vol":"0.67"},{"date":"2025-09-30","value":"0.37","vol":"0.76"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
产权比率 (%)	0.39	0.40	0.38	0.38	0.37
行业(%)	0.67	0.68	0.66	0.67	0.76

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"1.06","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.67","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.60","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.49","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[佛慈制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]